IS5897A - Úreídópíperidín afleiður sem valvís NK3 viðtakamótlyf fyrir manneskjur - Google Patents

Úreídópíperidín afleiður sem valvís NK3 viðtakamótlyf fyrir manneskjur

Info

Publication number
IS5897A
IS5897A IS5897A IS5897A IS5897A IS 5897 A IS5897 A IS 5897A IS 5897 A IS5897 A IS 5897A IS 5897 A IS5897 A IS 5897A IS 5897 A IS5897 A IS 5897A
Authority
IS
Iceland
Prior art keywords
ureidopiperidine
humans
selective
derivatives
receptor antagonists
Prior art date
Application number
IS5897A
Other languages
English (en)
Inventor
Aulombard Alain
Edmonds-Alt Xavier
Proietto Vincenzo
Van Broeck Didier
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of IS5897A publication Critical patent/IS5897A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
IS5897A 1998-10-09 2001-03-16 Úreídópíperidín afleiður sem valvís NK3 viðtakamótlyf fyrir manneskjur IS5897A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9812859A FR2784377B3 (fr) 1998-10-09 1998-10-09 Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant
PCT/FR1999/002355 WO2000021931A1 (fr) 1998-10-09 1999-10-04 Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk3 humains

Publications (1)

Publication Number Publication Date
IS5897A true IS5897A (is) 2001-03-16

Family

ID=9531536

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5897A IS5897A (is) 1998-10-09 2001-03-16 Úreídópíperidín afleiður sem valvís NK3 viðtakamótlyf fyrir manneskjur

Country Status (25)

Country Link
US (1) US6465489B1 (is)
EP (1) EP1119552A1 (is)
JP (1) JP2002527423A (is)
KR (1) KR20010085903A (is)
CN (1) CN1133622C (is)
AR (1) AR029148A1 (is)
AU (1) AU751592B2 (is)
BR (1) BR9914397A (is)
CA (1) CA2346729A1 (is)
CO (1) CO5180555A1 (is)
DZ (1) DZ2905A1 (is)
EA (1) EA003613B1 (is)
EE (1) EE200100214A (is)
FR (1) FR2784377B3 (is)
HU (1) HUP0201709A3 (is)
IL (1) IL142362A0 (is)
IS (1) IS5897A (is)
NO (1) NO20011779L (is)
NZ (1) NZ510779A (is)
PL (1) PL347910A1 (is)
SK (1) SK4642001A3 (is)
TR (1) TR200101030T2 (is)
TW (1) TW539669B (is)
WO (1) WO2000021931A1 (is)
YU (1) YU26001A (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068604A2 (en) 2000-03-14 2001-09-20 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
JP2005535650A (ja) * 2002-07-03 2005-11-24 グラクソ　グループ　リミテッド タキキニンアンタゴニストおよびセロトニン再取り込み阻害剤としての置換４−フェニル−ピペリジン−アミド
US20110144081A1 (en) 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
US9554659B2 (en) 2012-10-22 2017-01-31 Uwm Research Foundation, Inc. Infant sleep pod
WO2020101017A1 (ja) * 2018-11-15 2020-05-22 国立大学法人九州大学 Ｉｌ－３１介在性疾患の予防又は治療剤及び医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2738819B1 (fr) 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
EA003613B1 (ru) 2003-06-26
AR029148A1 (es) 2003-06-18
EP1119552A1 (fr) 2001-08-01
DZ2905A1 (fr) 2004-03-01
HUP0201709A3 (en) 2003-03-28
NZ510779A (en) 2003-07-25
KR20010085903A (ko) 2001-09-07
FR2784377A1 (fr) 2000-04-14
CN1329594A (zh) 2002-01-02
TR200101030T2 (tr) 2001-08-21
JP2002527423A (ja) 2002-08-27
NO20011779L (no) 2001-06-07
SK4642001A3 (en) 2001-09-11
FR2784377B3 (fr) 2000-11-17
TW539669B (en) 2003-07-01
CA2346729A1 (en) 2000-04-20
US6465489B1 (en) 2002-10-15
BR9914397A (pt) 2001-06-26
CN1133622C (zh) 2004-01-07
IL142362A0 (en) 2002-03-10
WO2000021931A1 (fr) 2000-04-20
AU5988799A (en) 2000-05-01
NO20011779D0 (no) 2001-04-06
PL347910A1 (en) 2002-04-22
AU751592B2 (en) 2002-08-22
EA200100299A1 (ru) 2001-10-22
CO5180555A1 (es) 2002-07-30
YU26001A (sh) 2003-04-30
EE200100214A (et) 2002-08-15
HUP0201709A2 (en) 2002-09-28

Similar Documents

Publication Publication Date Title
IS5706A (is) Adenosín A3 viðtakastillar
DE60026169D1 (de) Selektive neurokinin-antagonisten
NO965036L (no) Kinolinderivater som techykinin NK3 reseptor-antagonister
ATE280157T1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
IS4838A (is) Indól afleiður nytsamlegar sem innanþekjuviðtaka mótlyf
NO20012948D0 (no) Hydroksydifenylureasulfonamider som IL-8 reseptor antagonister
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
ID19623A (id) Antagonis reseptor vitronektin
NO20012411D0 (no) Pyrrolidin-derivater-CCR-3-reseptorantagonister
IS4953A (is) Tetrahýdrókínólín afleiður sem EAA mótlyf
ID26223A (id) Antagonis reseptor vitronektin
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
IS5532A (is) 2,3-setin indól efnasambönd sem cox-2 latar
DK1200073T3 (da) Selektive iGluR5-receptorantagonister til behandling af migræne
DE69919171D1 (de) Muskarin-rezeptor antagonisten
DK1068202T3 (da) 1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister
IS6821A (is) Samrunnar afleiður púríns sem mótlyf A1-adenósínviðtakans
ID24162A (id) Antagonis-antagonis reseptor vitronektin
NO20020979L (no) Selektive A2B-adenosinreseptorantagonister
ID28811A (id) Antagonis reseptor vitronektin
IS5746A (is) Tetrahýdrókínólín afleiður sem glysín mótlyf
IS8278A (is) Sýkóprópýl afleiður sem NK3 viðtaka mótlyf
IS5897A (is) Úreídópíperidín afleiður sem valvís NK3 viðtakamótlyf fyrir manneskjur
IS6429A (is) Indólafleiður sem MCP-1 viðtakamótlyf
BR9709911A (pt) Derivados de indola úteis como antagonistas receptores de 5-ht-2c